Twist Bioscience Corp SEC filings TWST

Twist Bioscience Corp has 1,007 filings in SEC EDGAR's recent list, going back to Oct 4, 2022. Its latest annual report, Form ARS, was filed on Jan 6, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (other events). The company's fiscal year ends on September 30.

Form Description Filed Period
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
10-Q/A Amended quarterly report Feb 26, 2026 Dec 31, 2025
10-Q Quarterly report Feb 2, 2026 Dec 31, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
10-Q Quarterly report Feb 3, 2025 Dec 31, 2024
10-Q Quarterly report Aug 2, 2024 Jun 30, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
10-Q Quarterly report Feb 2, 2024 Dec 31, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
10-Q Quarterly report Feb 7, 2023 Dec 31, 2022

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TWST (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1581280

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.